Exercise as a Buffer Against Stress-induced Overeating
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02936076 |
|
Recruitment Status :
Completed
First Posted : October 18, 2016
Results First Posted : October 23, 2019
Last Update Posted : March 29, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Obesity | Other: Exercise intervention Other: Delayed exercise intervention | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 49 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Exercise as a Buffer Against Stress-induced Overeating |
| Actual Study Start Date : | January 16, 2017 |
| Actual Primary Completion Date : | November 1, 2018 |
| Actual Study Completion Date : | May 21, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Exercise condition
Participants randomized to the exercise condition will participate in a 12-week exercise training program. The exercise intervention will consist of both supervised and unsupervised exercise sessions and progress to 200 minutes/week of moderate-intensity exercise. Exercise bouts will be spread across 4-6 days and be at least 20 minutes in duration. During supervised visits, heart rate will be monitored by a member of the research staff to ensure that exercise is within the prescribed intensity range and ratings of perceived exertion and feeling state will be assessed periodically. Unsupervised exercise will be verified using objective physical activity monitors.
|
Other: Exercise intervention |
|
Placebo Comparator: Delayed exercise condition
Participants randomized to the delayed exercise condition will be asked not to change their exercise or eating habits over the 12-week period and will complete the same assessment measures as the exercise condition. However, following the completion of the 12-week period, participants will be given two options: 1) receive a one-on-one session with an exercise physiologist at our center and receive a written exercise program, and at this time point all study obligations will be completed, or 2) complete the identical exercise protocol as the 'exercise' condition.
|
Other: Delayed exercise intervention |
- Stress-induced Overeating Measured Via Smartphone Surveys [ Time Frame: 12 weeks ]Participants completed EMA surveys (5x/day for 14 days). At each prompt they were asked if an eating episode occurred. If they indicated 'yes', they were asked to check all that apply: a) I ate past the point of feeling full, b) I ate more than usual, c) I had unplanned eating (i.e., consumed food when I don't usually eat and was not making up for a missed meal, or d) None of the above. If the participant responded with a, b, or c, it was classified as an 'overeating episode'. Further, at each prompt, participants were asked to the respond to the following: 'Right now I feel stressed' (1=not at all, 7=very much so). If the stress score was >=5 at the prompt just prior to an overeating episode, then it was considered a 'stress-induced overeating episode'.
- Percentage of Overeating Episodes Characterized as 'Overeating' [ Time Frame: 12 weeks ]If an eating episode occurred, participants were asked to check all that apply: a) I ate past the point of feeling full, b) I ate more than usual, c) I had unplanned eating (i.e., consumed food when I don't usually eat and was not making up for a missed meal, or d) None of the above. If response was a, b, or c, it was classified as an 'overeating episode'.
- Change in Body Weight (% Initial Weight) [ Time Frame: baseline and 12 weeks ]Percent weight change from baseline to 12 weeks
- Stress as Measured Via Questionnaire [ Time Frame: Baseline and 12 weeks ]The 10-item Perceived Stress Scale (Cohen 1988) was used to assess changes in stress by treatment arm from baseline to 12 weeks. Scores on this measure range from 0-40 with a higher score indicating greater perceived stress. Presented values are 12 week scores adjusted for baseline values.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Female
- 18-60 years of age
- BMI 25 to <40 kg/m2
- Physically inactive (<60 min/week of physical activity)
- Must own a smartphone
- Must be willing to receive and respond to text message prompts for 14 days at baseline, 6 and 12 weeks
Exclusion Criteria:
- Shift workers
- Individuals who do not endorse stress-eating
- Recent weight loss or current enrollment in a weight loss program
- Women who are pregnant or plan on becoming pregnant in the next 6 months
- Any medical condition that would limit participation in physical activity
- Diabetes
- Inability to walk without an assisted device
- Inability to meet exercise recommendations
- Failure to adequately complete all baseline assessment measures
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02936076
| United States, Rhode Island | |
| Weight Control and Diabetes Research Center | |
| Providence, Rhode Island, United States, 002903 | |
Documents provided by The Miriam Hospital:
| Responsible Party: | The Miriam Hospital |
| ClinicalTrials.gov Identifier: | NCT02936076 |
| Other Study ID Numbers: |
592916-14 K01DK100498 ( U.S. NIH Grant/Contract ) |
| First Posted: | October 18, 2016 Key Record Dates |
| Results First Posted: | October 23, 2019 |
| Last Update Posted: | March 29, 2021 |
| Last Verified: | August 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Hyperphagia Signs and Symptoms, Digestive |

